(firstQuint)Study of SM-88 in Advanced Cancers.

 The primary objective of this clinical trial is to assess the response rate and PFS in previously treated breast cancer patients.

 Additional objectives include the pharmacokinetics of multiple ascending doses of SM-88, a cocktail combination of 4 drugs being developed for the indication of metastatic breast cancer.

 Secondary objectives of this study include an assessment of safety and tolerability of ascending doses of orally administered SM-88.

 Additional response data will also be collected.

.

 Study of SM-88 in Advanced Cancers@highlight

The purpose of this study is to collect response and pharmacokinetic data on the oral administration of a cocktail combination of 4 drugs being developed for the indication of metastatic breast cancer.

